These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30647901)

  • 41. Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids.
    Tsartsali L; Papadopoulos M; Lagona E; Papadimitriou A; Kanaka-Gantenbein C; Louizou E; Kastania A; Priftis KN; Chrousos G
    Neuroimmunomodulation; 2012; 19(2):88-95. PubMed ID: 22248724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Respir Med; 2013 Aug; 107(8):1133-40. PubMed ID: 23769720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review.
    Powell H; Gibson PG
    Thorax; 2004 Dec; 59(12):1041-5. PubMed ID: 15563702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variable therapeutic response in asthma: a genetic perspective.
    Bhatnagar P; Guleria R; Kukreti R
    Per Med; 2006 Feb; 3(1):61-78. PubMed ID: 29783436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variation in uncontrolled childhood asthma despite ICS treatment.
    Leusink M; Vijverberg SJ; Koenderman L; Raaijmakers JA; de Jongste JC; Sterk PJ; Duiverman EJ; Onland-Moret NC; Postma DS; de Boer A; de Bakker PI; Koppelman GH; Maitland-van der Zee AH
    Pharmacogenomics J; 2016 Apr; 16(2):158-63. PubMed ID: 25963336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of asthma control indicators in measuring inhaled corticosteroid effectiveness in asthmatic smokers: a systematic review.
    Hayes CE; Nuss HJ; Tseng TS; Moody-Thomas S
    J Asthma; 2015; 52(10):996-1005. PubMed ID: 26418843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.
    Schmier JK; Halpern MT; Jones ML
    Drugs Aging; 2005; 22(9):717-29. PubMed ID: 16156676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenetics of Pediatric Asthma: Current Perspectives.
    Perez-Garcia J; Espuela-Ortiz A; Lorenzo-Diaz F; Pino-Yanes M
    Pharmgenomics Pers Med; 2020; 13():89-103. PubMed ID: 32256100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asthma genomics and pharmacogenomics.
    Daya M; Ortega VE
    Curr Opin Immunol; 2020 Oct; 66():136-142. PubMed ID: 33171417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis.
    Adikusuma W; Chou WH; Lin MR; Ting J; Irham LM; Perwitasari DA; Chang WP; Chang WC
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene polymorphisms in asthma: a narrative review.
    Shi F; Zhang Y; Qiu C
    Ann Transl Med; 2022 Jun; 10(12):711. PubMed ID: 35845533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic Predictors of Asthma Phenotypes and Treatment Response.
    Hernandez-Pacheco N; Pino-Yanes M; Flores C
    Front Pediatr; 2019; 7():6. PubMed ID: 30805318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lessons Learned From GWAS of Asthma.
    Kim KW; Ober C
    Allergy Asthma Immunol Res; 2019 Mar; 11(2):170-187. PubMed ID: 30661310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of genetic sampling methodologies for candidate-gene analyses.
    Sun J; Tung SR; Wang D; Kitzmiller JP; Smith S
    J Transl Sci; 2019 Jun; 5(3):. PubMed ID: 31749990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review of association studies of common variants associated with idiopathic congenital talipes equinovarus (ICTEV) in humans in the past 30 years.
    Yong BC; Xun FX; Zhao LJ; Deng HW; Xu HW
    Springerplus; 2016; 5(1):896. PubMed ID: 27386344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contributions of candidate-gene associations studies and genome-wide association studies (GWAS) to identification of genetic variations associated with asthma.
    Friedrich F; de Castro MÂUL; da Costa Herter E; Prestes LM; Pinto LA
    Ann Transl Med; 2022 Nov; 10(21):1151. PubMed ID: 36467360
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacogenomic Testing in the Asthma Clinic: Will Inhaled Corticosteroids Lead the Way?
    Blake K; Raissy H
    Pediatr Allergy Immunol Pulmonol; 2012 Mar; 25(1):44-47. PubMed ID: 35927839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.